US approves maternal vaccine to prevent RSV in infants, Health News, ET HealthWorld

US approves maternal vaccine to prevent RSV in infants, Health News, ET HealthWorld

This image provided by Pfizer shows the RSV vaccine. U.S. regulators on Monday, Aug. 21, 2023, approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. (Pfizer via AP) Washington, Aug 21, 2023 -The United States on Monday became the first country to approve … Read more

Vaccine: US FDA approves Pfizer’s maternal RSV vaccine to protect infants

Vaccine: US FDA approves Pfizer’s maternal RSV vaccine to protect infants

The US Food and Drug Administration on Monday approved Pfizer‘s respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies. The approval allows the vaccine to be given to women 32 to 36 weeks into a pregnancy to prevent lower respiratory tract infection … Read more